These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


342 related items for PubMed ID: 17956258

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Regulation of the lipidation of beta-secretase by statins.
    Parsons RB, Farrant JK, Price GC, Subramaniam D, Austen BM.
    Biochem Soc Trans; 2007 Jun; 35(Pt 3):577-82. PubMed ID: 17511656
    [Abstract] [Full Text] [Related]

  • 3. A novel beta-site amyloid precursor protein cleaving enzyme (BACE) isoform regulated by nonsense-mediated mRNA decay and proteasome-dependent degradation.
    Tanahashi H, Tabira T.
    Neurosci Lett; 2007 Nov 27; 428(2-3):103-8. PubMed ID: 17961921
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Protein lipidation of BACE.
    Parsons RB, Austen BM.
    Biochem Soc Trans; 2005 Nov 27; 33(Pt 5):1091-3. PubMed ID: 16246052
    [Abstract] [Full Text] [Related]

  • 7. Modeling of substrate specificity of the Alzheimer's disease amyloid precursor protein beta-secretase.
    Sauder JM, Arthur JW, Dunbrack RL.
    J Mol Biol; 2000 Jul 07; 300(2):241-8. PubMed ID: 10873463
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. BACE: Therapeutic target and potential biomarker for Alzheimer's disease.
    Evin G, Barakat A, Masters CL.
    Int J Biochem Cell Biol; 2010 Dec 07; 42(12):1923-6. PubMed ID: 20817005
    [Abstract] [Full Text] [Related]

  • 11. Promising anti-Alzheimer's dimer bis(7)-tacrine reduces beta-amyloid generation by directly inhibiting BACE-1 activity.
    Fu H, Li W, Luo J, Lee NT, Li M, Tsim KW, Pang Y, Youdim MB, Han Y.
    Biochem Biophys Res Commun; 2008 Feb 15; 366(3):631-6. PubMed ID: 18039469
    [Abstract] [Full Text] [Related]

  • 12. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K, Solano I, Mann D, Lemere C, Mercken M, Trojanowski JQ, Lee VM.
    Acta Neuropathol; 2006 Aug 15; 112(2):163-74. PubMed ID: 16865398
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Progress toward the discovery and development of efficacious BACE inhibitors.
    Durham TB, Shepherd TA.
    Curr Opin Drug Discov Devel; 2006 Nov 15; 9(6):776-91. PubMed ID: 17117686
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Decreased expression of GGA3 protein in Alzheimer's disease frontal cortex and increased co-distribution of BACE with the amyloid precursor protein.
    Santosa C, Rasche S, Barakat A, Bellingham SA, Ho M, Tan J, Hill AF, Masters CL, McLean C, Evin G.
    Neurobiol Dis; 2011 Jul 15; 43(1):176-83. PubMed ID: 21440067
    [Abstract] [Full Text] [Related]

  • 20. Pathogenic mechanisms in Alzheimer's disease.
    Pastorino L, Lu KP.
    Eur J Pharmacol; 2006 Sep 01; 545(1):29-38. PubMed ID: 16904664
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.